← Back to all signals
RESEARCH PAPER ANALYSIS

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

AI interpretation is pending for this paper.

Open original publication →
PMID42658095
JournalCancer
Publication Date2026-09-01
Ingested2026-08-28 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Cancer statistics for Asian American and Native Hawaiian and Pacific Islander (NHPI) people are usually aggregated, masking substantial variation within this heterogeneous population. Herein, the American Cancer Society reports cancer incidence and survival for 8 Asian American and 3 NHPI ethnic groups. METHODS: The authors used population-based cancer registry data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, for Asian American and NHPI ethnic groups from 2000 through 2022. RESULTS: During 2018-2022, overall cancer incidence ranged from 218.3 per 100,000 Kampuchean people to 474.5 per 100,000 Native Hawaiian people, which was 1.5 times higher than the rate for the aggregated Asian American and NHPI population (307.3 per 100,000). High incidence among Native Hawaiian people is largely driven by the highest rates of female breast, colorectal, and prostate cancers, whereas infection-related cancers were highest among Asian American ethnic groups. For example, liver and stomach cancer incidence is highest among Vietnamese (22.2 per 100,000) and Korean people (17.8 per 100,000), respectively, both of which were nearly twice that in Native Hawaiian people (12.9 and 9.6 per 100,000, respectively). Native Hawaiian and Samoan women are twice and 3 times as likely, respectively, to be diagnosed with uterine corpus cancer as aggregated Asian American and NHPI women or White women. Five-year relative survival ranges from 42% in Laotians to 74% in Asian Indians/Pakistanis, with largest differences for colorectal (43% in Laotians to 72% in Asian Indians/Pakistanis) and prostate (63% in Kampucheans to 97% in Japanese) cancers. CONCLUSIONS: Wide variation in cancer risk within the Asian American and NHPI population highlights the critical need for disaggregated data to effectively target cancer prevention and control interventions.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Predisposing, Precipitating, Perpetuating, and Protective Factors Associated With Distress in the Siblings of Children With Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 71.4 2 Germline POT1 variants are associated with long telomeres and an unexpected broad spectrum of malignancies. Genetics in medicine open 57.0 3 Risk Factors for Pouch Neoplasia in Patients With Inflammatory Bowel Disease: A Case-Control Study. Gastro hep advances 69.0 4 Neuroblastoma Metastasis to the Mandible in Children: A Case Report and Focused Narrative Review of Reported Cases. Children (Basel, Switzerland) 57.5 5 Proteomic Profiling of Bone Marrow Aspirates from Patients with Methotrexate- and Vincristine-Resistant B-Cell Acute Lymphoblastic Leukemia: A Retrospective Analysis. Pharmaceuticals (Basel, Switzerland) 71.7 6 A Tale of Two Cohorts: Comparing HPV Vaccination Barriers and Facilitators Among HIV-Negative and HIV-Positive Women in Tennessee. International journal of environmental research and public health 60.0 7 A Sanguinarine Analogue Targeting ROS Signaling Exhibits Anti-Tumour Effects by Inducing Apoptosis and Ferroptosis in Osteosarcoma. Antioxidants (Basel, Switzerland) 74.7 8 Prepubertal Screening for Testicular Adrenal Rest Tumors in Boys with Classic Congenital Adrenal Hyperplasia: Emerging Evidence and Practical Implications. Children (Basel, Switzerland) 57.0 9 Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization. Pharmaceuticals (Basel, Switzerland) 85.98 10 [Opsoclonus Myoclonus Ataxia: Diagnostic pathway and immunosuppressive treatment in opsoclonus-myoclonus]. Medicina 68.04 11 [Sturge-Weber syndrome: comparative analysis between clinical manifestations and neuro-radiological findings]. Medicina 57.6 12 Image-Based Assessment of Anti-TNF Treatment Outcomes in Pediatric CRMO/CNO: A Single-Center Case Series. Children (Basel, Switzerland) 61.84 13 Understanding HPV Vaccine Uptake Among American Indian and Alaska Native College Students: A Scoping Review. International journal of environmental research and public health 58.7 14 Genetic Susceptibility to Anthracycline-Induced Cardiotoxicity in Australian Pediatric Cancer Patients: A Case-Control Study. JACC. Advances 54.62 15 Infection-Related Adverse Events of Tisagenlecleucel in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A FAERS Pharmacovigilance Study. Children (Basel, Switzerland) 72.16 16 Catalase Defines Radiotherapy Resistance and a Therapeutic Vulnerability in Rhabdomyosarcoma. International journal of molecular sciences 64.88 17 Multidisciplinary Management of Pediatric Craniopharyngioma: From Diagnosis to Long-Term Outcomes. Biomedicines 67.4 18 Idiopathic Syringomyelia: A Systematic Scoping Review. Journal of clinical medicine 73.5 19 Beyond Oligodendroglioma: An Integrated Diagnostic Approach to CNS Tumors with Oligodendroglioma-like Morphology, with a Focus on Morphological Pitfalls, Immunoprofiles, and Molecular Signatures. International journal of molecular sciences 56.0 20 Diagnostic Intervals in Children, Adolescents and Young Adults with Primary Bone Sarcoma: A Systematic Review. Cancers 79.6 21 Next-Generation Sequencing Refines Diagnosis and Expands Precision Medicine Opportunities in Soft Tissue Sarcomas. International journal of molecular sciences 68.64 22 Closing the evidence gap: why childhood cancer research must include fathers. Public health reviews 28.5 23 Prognostic implications of CD123 in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective analysis. Frontiers in pediatrics 79.8 24 Revisiting the hematological manifestations of vitamin B12 deficiency. Frontiers in nutrition 59.9 25 Efficacy and Safety of Adjusting Antimicrobial Therapy in Episodes of Fever and Neutropenia Catalogued as Fever of Unknown Origin in Children with Cancer: A Randomized Clinical Trial. Antibiotics (Basel, Switzerland) 76.64 26 Health Economic Assessment of PM2.5 Originating from Residential Wood Combustion-A Case Study in Northern Sweden. International journal of environmental research and public health 47.7 27 Nanotechnology in Pediatric Neurology: Applications and Innovations. Pharmaceutics 77.9 28 Disparities in Area Socioeconomic Development and Pediatric Cancer Survival in Romania-A National Pediatric Registry Study on Multiple Geographic Levels. Cancers 71.62 29 Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk. Cancers 64.92 30 Precision Medicine in Dermatology: MEK Inhibition and MAPK Pathway Modulation for Congenital Melanocytic Nevi. Biomedicines 70.44 31 Pancreatoblastoma: A Descriptive and Comparative Analysis with Pancreatic Ductal Adenocarcinoma Using SEER Data. Cancers 63.1 32 Cytokines in First-Episode Psychosis: Implications for Pathophysiology: A Narrative Literature Review. Brain sciences 57.0
PATIENT-FRIENDLY SUMMARY

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic